Science & Technology
(U50)
990 on File
KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY
Financial strength (30%)
72/100
Reliability (20%)
55/100
Effectiveness (25%)
75/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$11.4M
Total Revenue
$12.9M
Total Expenses
$19.4M
Net Assets
39
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
66.4%
Fundraising Efficiency
N/A
Operating Reserve
18.02x
Liability-to-Asset
11.5%
Revenue Diversification
75.7%
Executive Compensation
$1.1M
Compared with Peers
FY 2025
Compared with 36 similar organizations
(United States, Science & Technology, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
66.4% | 82.8% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
27.6% | 14.5% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
6.1% | 0.4% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
18.0 mo | 12.2 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
11.5% | 31.2% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
75.7% | 84.6% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-6.0% | -0.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
6.5% | 3.2% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-13.4% | 0.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $11.4M | $12.9M | $19.4M | 66.4% | 39 |
| 2024 | $12.1M | $12.1M | $19.8M | 68.3% | 41 |
| 2023 | $14.9M | $13.2M | $18.7M | 67.3% | 38 |
| 2022 | $9.3M | $10.1M | $16.5M | 58.9% | 38 |
| 2021 | $9.7M | $7.3M | N/A | — | 40 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.